1.
Eric Vallabh Minikel, Jeffery L. Painter, Coco Chengliang Dong, Matthew R. Nelson. Refining the impact of genetic evidence on clinical success. Nature. 2024:1-6. doi:10.1038/s41586-024-07316-0
Genetic Predisposition to Disease
1.
Noelia Antón-Bolaños, Irene Faravelli, Tyler Faits, et al. Brain Chimeroids reveal individual susceptibility to neurotoxic triggers. Nature. 2024;631(8019):142-149. doi:10.1038/s41586-024-07578-8
1.
Noelia Antón-Bolaños, Irene Faravelli, Tyler Faits, et al. Brain Chimeroids reveal individual susceptibility to neurotoxic triggers. Nature. 2024;631(8019):142-149. doi:10.1038/s41586-024-07578-8
1.
Julie Jerber, Daniel D. Seaton, Anna S. E. Cuomo, et al. Population-scale single-cell RNA-seq profiling across dopaminergic neuron differentiation. Nature Genetics. 2021;53(3):304-312. doi:10.1038/s41588-021-00801-6
1.
Cameron S. Cowan, Magdalena Renner, Martina De Gennaro, et al. Cell Types of the Human Retina and Its Organoids at Single-Cell Resolution. Cell. 2020;182(6):1623-1640.e34. doi:10.1016/j.cell.2020.08.013
1.
Dorothée Diogo, Chao Tian, Christopher S. Franklin, et al. Phenome-wide association studies across large population cohorts support drug target validation. Nature Communications. 2018;9(1):4285. doi:10.1038/s41467-018-06540-3
1.
Matthew R. Nelson, Hannah Tipney, Jeffery L. Painter, et al. The support of human genetic evidence for approved drug indications. Nature Genetics. 2015;47(8):856-860. doi:10.1038/ng.3314